Overview

SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The main goal of this research is to use behavioral, brain, and clinical data to determine which type of antidepressant might be optimal before people with depression start treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Mclean Hospital
Treatments:
Bupropion
Sertraline